Big Pharma is sticking to the recent molecular glue investment trend, with Pfizer now the latest major drugmaker to get in on ...
Pfizer is already active in the protein degrader area, having partnered with Arvinas in a $2 billion-plus deal signed in 2021 ...
TRIANA Biomedicines has entered into a strategic collaboration and licensing agreement with US pharma giant Pfizer to ...
The next time you skip a workout or stay up late, consider this: your brain might still be feeling the effects two weeks from ...
Researchers from Aalto University and the University of Oulu in Finland tracked a neuroscientist’s brain and behavioral ...
The short-term wave was reflective of rapid responses to a behavior, like struggling to focus after a poor night's sleep. Meanwhile, the long-term wave suggests more gradual, lasting effects of a ...